Testosterone and YK-11 Interaction

Monitor
Researched 90% confidence

Testosterone and YK-11 have an interaction requiring monitoring for interaction with 90% confidence. Some users run a low-dose testosterone base (e.g., 100-150 mg/week TRT) alongside YK-11 to mitigate the hormonal suppression caused by YK-11's AR agonist activity. A testosterone base can help maintain libido, mood, and energy levels during the cycle. However, combining exogenous testosterone with a 17-alpha alkylated compound increases the overall hormonal and hepatic burden. Liver function and estradiol should be monitored closely. Both compounds affect the gonads and heart and liver, so monitoring these systems is recommended.

Compound Profiles

Testosterone

Anabolic-Androgenic Steroid | Primary Male Sex Hormone

Testosterone exerts its effects primarily through binding to the intracellular androgen receptor (AR), forming a hormone-receptor complex that translocates to the nucleus and modulates gene transcription. This drives protein synthesis in skeletal muscle (anabolic effect), stimulates erythropoietin production in the kidneys to increase red blood cell mass, promotes osteoblast activity and bone mineral density, and regulates libido and cognitive function.

Half-life: ~8 days (cypionate) Typical dose: 100-200 mg/week (TRT) anabolic, sexual health, metabolic
5 alpha reductaseandrogen receptoraromataseepo receptor androgeniccarcinogenic riskestrogenichematocrit raising
View full profile

YK-11

Myostatin Inhibitor & SARM Hybrid | Experimental

YK-11 exerts its effects through two distinct but complementary pathways. First, it acts as a partial agonist of the androgen receptor (AR).

Half-life: ~6-10 hours Typical dose: 5-10 mg/day sarm, anabolic
androgen receptorepo receptormyostatintgf beta androgenicblood pressure raisingcarcinogenic riskhepatotoxic
View full profile

Combined Organ Load

Gonads
elevated
Heart
moderate
Liver
moderate
Pancreas
low

Shared Safety Flags

2x 2 androgenic compounds (Testosterone, YK-11). Additive androgenic load — increased risk of hair loss, acne, prostate effects.
2x 2 compounds share the carcinogenic-risk safety flag (Testosterone, YK-11). Monitor accordingly.
2x 2 hepatotoxic compounds (Testosterone, YK-11). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 HPTA-suppressive compounds (Testosterone, YK-11). Deep hormonal shutdown expected — plan extended PCT.
2x 2 compounds disrupt lipids (Testosterone, YK-11). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Testosterone, YK-11). Monitor accordingly.

Frequently Asked Questions

Can I take Testosterone with YK-11?

Yes, but with caution. Some users run a low-dose testosterone base (e.g., 100-150 mg/week TRT) alongside YK-11 to mitigate the hormonal suppression caused by YK-11's AR agonist activity. A testosterone base can help maintain libido, mood, and energy levels during the cycle. However, combining exogenous testosterone with a 17-alpha alkylated compound increases the overall hormonal and hepatic burden. Liver function and estradiol should be monitored closely. Regular monitoring is advised.

Is Testosterone and YK-11 safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: androgenic, carcinogenic risk, hepatotoxic, hpta suppressive, lipid disrupting, teratogenic. Monitor accordingly.

What are the interactions between Testosterone and YK-11?

Some users run a low-dose testosterone base (e.g., 100-150 mg/week TRT) alongside YK-11 to mitigate the hormonal suppression caused by YK-11's AR agonist activity. A testosterone base can help maintain libido, mood, and energy levels during the cycle. However, combining exogenous testosterone with a 17-alpha alkylated compound increases the overall hormonal and hepatic burden. Liver function and estradiol should be monitored closely. This assessment has 90% confidence and is based on documented research data.

How should I time Testosterone and YK-11?

Testosterone has a half-life of ~8 days (cypionate) and YK-11 has a half-life of ~6-10 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Testosterone vs YK-11

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.